Literature DB >> 24832864

Using poisons information service data to assess the acute harms associated with novel psychoactive substances.

D M Wood1, S L Hill, S H L Thomas, P I Dargan.   

Abstract

Novel psychoactive substances (NPS) can cause significant acute toxicity but usually little is known about their toxicity when they enter the recreational drug scene. Current data sources include online user forums, user questionnaires, case reports/series, and deaths; however, these are limited by their focus on sub-populations and generally include severe cases and specific geographical areas. Approximately 54% of countries have at least one poisons information service (in 2012 there were 274 worldwide) providing advice to healthcare professionals and/or the public on poisoning. They provide advice on recreational drug and NPS toxicity. In 2012, 2.5% of telephone enquiries to the UK National Poisons Information Service and 2.4% of enquiries to US poisons centres related to recreational drugs. Data are collected at population level and can be used to complement other data sources with clinical details on acute NPS toxicity and geographical/time patterns of toxicity. Like other acute NPS toxicity data, poisons centre data should be interpreted within their limitations, notably the absence of analytical confirmation and reliance on secondary reporting of clinical features. This manuscript demonstrates the breadth and depth of poisons information service data in the literature with a focus on mephedrone and synthetic cannabinoid-receptor agonists. In our opinion it would be possible to develop a more robust and systematic reporting system using a network of poisons information services both within and across countries that would be complimentary to other datasets on acute NPS toxicity and allow more accurate data triangulation.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  acute toxicity; data triangulation; novel psychoactive substances; poisons information service; recreational drugs

Mesh:

Substances:

Year:  2014        PMID: 24832864     DOI: 10.1002/dta.1671

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  6 in total

1.  A novel psychoactive substance poses a new challenge in the management of paranoid schizophrenia.

Authors:  Caroline Anderson; Christopher Morrell; David Marchevsky
Journal:  BMJ Case Rep       Date:  2015-05-06

2.  Stereoselective Differences between the Reinforcing and Motivational Effects of Cathinone-Derived 4-Methylmethcathinone (Mephedrone) In Self-Administering Rats.

Authors:  Helene L Philogene-Khalid; Steven J Simmons; Sunil Nayak; Rose M Martorana; Shu H Su; Yohanka Caro; Brona Ranieri; Kathryn DiFurio; Lili Mo; Taylor A Gentile; Ali Murad; Allen B Reitz; John W Muschamp; Scott M Rawls
Journal:  ACS Chem Neurosci       Date:  2017-09-22       Impact factor: 4.418

Review 3.  Synthetic cathinones: a new public health problem.

Authors:  Laurent Karila; Bruno Megarbane; Olivier Cottencin; Michel Lejoyeux
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

4.  Review of the many faces of synthetic cannabinoid toxicities.

Authors:  Azita Alipour; Puja Baldev Patel; Zaheera Shabbir; Stephen Gabrielson
Journal:  Ment Health Clin       Date:  2019-03-01

5.  New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.

Authors:  Eliza Kurcevič; Rick Lines
Journal:  Harm Reduct J       Date:  2020-11-30

6.  Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services.

Authors:  Manuela Carla Monti; Jill Zeugin; Konrad Koch; Natasa Milenkovic; Eva Scheurer; Katja Mercer-Chalmers-Bender
Journal:  Drug Test Anal       Date:  2022-02-02       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.